The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects

por Mohamed, Mohamed‐Eslam F., Trueman, Sheryl, Feng, Tian, Friedman, Alan, Othman, Ahmed A.
Publicado 2018

Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics

por Mohamed, Mohamed‐Eslam F., Trueman, Sheryl, Feng, Tian, Anderson, Jaclyn, Marbury, Thomas C., Othman, Ahmed A.
Publicado 2019

Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics

por Trueman, Sheryl, Mohamed, Mohamed‐Eslam F., Feng, Tian, Lacerda, Ana Paula, Marbury, Thomas, Othman, Ahmed A.
Publicado 2019

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation

por Mohamed, Mohamed-Eslam F., Trueman, Sheryl, Othman, Ahmed A., Han, Jian-Hwa, Ju, Tzuchi R., Marroum, Patrick
Publicado 2019

Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate

por Mohamed, Mohamed‐Eslam F., Minocha, Mukul, Trueman, Sheryl, Feng, Tian, Enejosa, Jeffrey, Fisniku, Ogert, Othman, Ahmed A.
Publicado 2020